DRB1*15 and DRB1*03 extended haplotype inter-action in primary Sjogren's syndrome genetic susceptibility

Clinical and Experimental Rheumatology

Volumn 16, Issue 6, 1998, Pages 725-728

  Jean, S ^a,b   Quelvennec, E ^a   Alizadeh, M ^a   Guggenbuhl, P ^b   Birebent, B ^a   Perdriger, A ^b   Grosbois, B ^b   Pawlotsky, P Y ^b   Semana, G ^a,c  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c Lab Universitaire d'Immunologie   (France)

Author keywords

Genetic susceptibility; HLA DRB1; MHC genes; Sjogren's syndrome; TAP genes

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR1 ANTIGEN; TUMOR NECROSIS FACTOR; ABC TRANSPORTER; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; MICROSATELLITE DNA; TAP2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; GENE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HETEROZYGOTE;

ATP-BINDING CASSETTE TRANSPORTERS; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HLA-DR ANTIGENS; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031593489     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. FOX RI: Sjögren's syndrome. Controversies and progress. Clin Lab Med 1997; 17: 431-44.
2. YANNOPOULOS DI, RONCIN S, LAMOUR A, PENNEC YL, MOUTSOPOULOS HM, YOUINOU P: Conjunctival epithelial cells from patients with Sjögren's syndrome in appropriately express major histocompatibility complex molecules, La(SSB) antigen and heat-shock proteins. J Clin Immunol 1992; 12: 259-5.
3. LINDAHL G, HEDFORS E, KLARESKOG L, FORSUM U: Epithelial HLA-D expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1985; 61: 475-82.
4. CHUSED TM, KASSAN SS, OPELZ G, MOUTSOPOULOS HM, TERASAKI PI: Sjögren's syndrome association with HLA-Dw3. N Engl J Med 1977; 296: 895-7.
5. ARNETT FC, BIAS WB, REVEILLE JD: Genetic studies in Sjögren's syndrome and systemic lupus erythematosus. J Autoimmunity 1989; 2: 403-13.
6. D'ALFONSO A, RICHIARDI PM: A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-4.
7. UDALOVA IA, NEDOSPASOV SA, WEBB GC, CHAPLIN DD, TURETSKAYA RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-6.
8. POCIOT F, BRIANT L, JONGENEEL CV et al.: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-31.
9. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al.: Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicenter study. Ann Rheum Dis 1996; 55: 116-2.
10. GUGGENBUHL P, JEAN S, JEGO P et al.: Primary Sjögren's syndrome: Role of the HLA-DRB1*0301-*1501 heterozygotes. J Rheumatol 1998; 25: 900-5.
11. HMIDA A, GAUTHIER A, DRIDDI A, GENETET B, BOUKEF K, SEMANA G: HLA class II gene polymorphism in Tunisian. Tissue Antigens 1995; 45: 63-8
12. MERCIER B, FEREC C, DUFOSSE F, HUART JJ: Improvement in HLA-DQB typing by PCR-RFLP: Introduction of a constant restriction site in one of the primers for digestion control. Tissue Antigens 1992; 40: 86-9.
13. MOINS-TEISSERENC H, BOBRYNINA V, LOISEAU P, CHARRON D: New polymorphism within the human TAP1 and TAP2 coding regions. Immunogenetics 1994; 40: 242.
14. MAUGENDRE D, ALIZADEH M, GAUTHIER A et al.: Genetic heterogeneity between type 1a and type Ib insulin-dependent diabetes mellitus: HLA class II and TAP gene analysis. Tissue Antigens 1996; 48: 540-8.
15. UDALOVA IA, NEDOSPASOV SA, WEBB GC, CHAPLIN DD, TURETSKAVA RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-6.
16. KANG HI, FEI HM, SAITO I et al.: Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's Syndrome. J Immunol 1993; 150: 3615-23
17. STEPHENSON FH, WALKER D, CAVANAGH G, KELLY C, GRIFFITHS I: Linkage studies of HLA and primary Sjögren's syndrome in multi-case families. Arthritis Rheum 1993; 36: 473-84.
18. FOSTER H, WALKER D, CHARLES P, KELLY C, CAVANAGH G, GRIFFITHS I: Association of DR3 with susceptibility to and severity of primary Sjögren's syndrome in a family study. Br J Rheumatol 1992; 31: 309-14.
19. FEI HM, KANG H, SCHARF S, ERLICH H, PEEBLES C, FOX R: Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production. J Clin Lab Anal 1991; 5: 382-91.
20. MORLING N, ANDERSEN V, FUGGER L et al.: Immunogenetics of rheumatoid arthritis and primary Sjögren's syndrome: DNA polymorphism of HLA class II genes. Dis Markers 1991; 9: 289-96.
21. REVEILLE JD, ARNETT FC: The immunogenetics of Sjögren's syndrome. Rheum Dis Clin North Am 1992; 18: 539-50.
22. KUMAGAI S, KANAGAWA S, MORINOBU A et al.: Association of a new allele of the TAP2* Bky2 (Val577), with susceptibility to Sjögren's syndrome. Arthritis Rheum 1997; 40: 1685-92.
23. CHICZ RM, URBAN RG, GORGA JC, VlGNALI DA, LANE WS, STROMINGER JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27-47.
24. NAMEKAWA T, KURODA K, KATO T et al.: Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjögren's syndrome. J Rheumatol 1995; 22: 2092-9.